BAL PHARMA
|
BAL PHARMA Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹303 Cr | ₹339 Cr | ₹304 Cr | ₹281 Cr | ₹251 Cr |
| Sales | ₹294 Cr | ₹326 Cr | ₹302 Cr | ₹280 Cr | ₹247 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | ₹0.01 Cr | ₹0.12 Cr | ₹0.00 Cr | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹8.81 Cr | ₹13 Cr | ₹2.51 Cr | ₹1.52 Cr | ₹3.58 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹303 Cr | ₹339 Cr | ₹304 Cr | ₹281 Cr | ₹251 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-7.05 Cr | ₹-1.07 Cr | ₹-18 Cr | ₹-4.90 Cr | ₹5.05 Cr |
| Raw Material Consumed | ₹150 Cr | ₹177 Cr | ₹177 Cr | ₹161 Cr | ₹136 Cr |
| Opening Raw Materials | ₹25 Cr | ₹36 Cr | ₹31 Cr | ₹23 Cr | ₹25 Cr |
| Purchases Raw Materials | ₹143 Cr | ₹154 Cr | ₹171 Cr | ₹161 Cr | ₹123 Cr |
| Closing Raw Materials | ₹33 Cr | ₹25 Cr | ₹36 Cr | ₹31 Cr | ₹23 Cr |
| Other Direct Purchases / Brought in cost | ₹15 Cr | ₹11 Cr | ₹11 Cr | ₹8.43 Cr | ₹10 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹8.29 Cr | ₹8.73 Cr | ₹7.73 Cr | ₹5.89 Cr | ₹4.98 Cr |
| Electricity & Power | ₹4.92 Cr | ₹5.36 Cr | ₹4.52 Cr | ₹3.69 Cr | ₹3.30 Cr |
| Oil, Fuel & Natural gas | ₹3.01 Cr | ₹3.08 Cr | ₹3.00 Cr | ₹1.92 Cr | ₹1.49 Cr |
| Coals etc | - | - | - | - | - |
| Other power & fuel | ₹0.36 Cr | ₹0.29 Cr | ₹0.21 Cr | ₹0.28 Cr | ₹0.18 Cr |
| Employee Cost | ₹62 Cr | ₹60 Cr | ₹55 Cr | ₹47 Cr | ₹42 Cr |
| Salaries, Wages & Bonus | ₹56 Cr | ₹54 Cr | ₹49 Cr | ₹42 Cr | ₹37 Cr |
| Contributions to EPF & Pension Funds | ₹2.24 Cr | ₹2.37 Cr | ₹1.90 Cr | ₹1.61 Cr | ₹1.74 Cr |
| Workmen and Staff Welfare Expenses | ₹2.97 Cr | ₹2.96 Cr | ₹3.04 Cr | ₹2.65 Cr | ₹2.22 Cr |
| Other Employees Cost | ₹1.22 Cr | ₹1.58 Cr | ₹1.08 Cr | ₹1.10 Cr | ₹1.00 Cr |
| Other Manufacturing Expenses | ₹26 Cr | ₹29 Cr | ₹28 Cr | ₹22 Cr | ₹19 Cr |
| Sub-contracted / Out sourced services | ₹2.14 Cr | ₹4.41 Cr | ₹4.93 Cr | ₹3.05 Cr | ₹3.28 Cr |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | ₹5.28 Cr | ₹5.63 Cr | ₹5.41 Cr | ₹4.64 Cr | ₹3.20 Cr |
| Packing Material Consumed | ₹15 Cr | ₹16 Cr | ₹14 Cr | ₹12 Cr | ₹10 Cr |
| Other Mfg Exp | ₹3.49 Cr | ₹3.08 Cr | ₹3.60 Cr | ₹2.44 Cr | ₹2.07 Cr |
| General and Administration Expenses | ₹13 Cr | ₹13 Cr | ₹10 Cr | ₹8.07 Cr | ₹5.47 Cr |
| Rent , Rates & Taxes | ₹3.15 Cr | ₹4.02 Cr | ₹2.97 Cr | ₹2.08 Cr | ₹1.49 Cr |
| Insurance | ₹1.51 Cr | ₹1.46 Cr | ₹0.74 Cr | ₹0.53 Cr | ₹0.46 Cr |
| Printing and stationery | ₹0.42 Cr | ₹0.45 Cr | ₹0.44 Cr | ₹0.32 Cr | ₹0.32 Cr |
| Professional and legal fees | ₹2.69 Cr | ₹2.66 Cr | ₹2.30 Cr | ₹2.53 Cr | ₹1.50 Cr |
| Traveling and conveyance | ₹3.36 Cr | ₹2.82 Cr | ₹2.02 Cr | ₹0.68 Cr | ₹0.62 Cr |
| Other Administration | ₹1.83 Cr | ₹1.67 Cr | ₹1.69 Cr | ₹1.93 Cr | ₹1.09 Cr |
| Selling and Distribution Expenses | ₹20 Cr | ₹19 Cr | ₹16 Cr | ₹15 Cr | ₹10 Cr |
| Advertisement & Sales Promotion | ₹4.82 Cr | ₹2.85 Cr | ₹3.08 Cr | ₹2.25 Cr | ₹1.57 Cr |
| Sales Commissions & Incentives | ₹7.46 Cr | ₹8.79 Cr | ₹3.83 Cr | ₹2.64 Cr | ₹2.58 Cr |
| Freight and Forwarding | ₹7.87 Cr | ₹6.80 Cr | ₹9.37 Cr | ₹9.93 Cr | ₹6.12 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹0.02 Cr | ₹0.10 Cr | ₹0.08 Cr | ₹0.05 Cr | ₹0.01 Cr |
| Miscellaneous Expenses | ₹0.71 Cr | ₹2.57 Cr | ₹2.72 Cr | ₹3.51 Cr | ₹3.79 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | - | ₹0.19 Cr | ₹0.18 Cr | ₹0.16 Cr | ₹0.21 Cr |
| Losson disposal of fixed assets(net) | - | - | - | - | - |
| Losson foreign exchange fluctuations | - | ₹0.91 Cr | ₹1.42 Cr | ₹0.00 Cr | ₹1.86 Cr |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹0.71 Cr | ₹1.47 Cr | ₹1.12 Cr | ₹3.35 Cr | ₹1.72 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹273 Cr | ₹308 Cr | ₹279 Cr | ₹257 Cr | ₹226 Cr |
| Operating Profit (Excl OI) | ₹30 Cr | ₹31 Cr | ₹25 Cr | ₹24 Cr | ₹25 Cr |
| Other Income | ₹2.20 Cr | ₹2.85 Cr | ₹0.94 Cr | ₹5.15 Cr | ₹1.14 Cr |
| Interest Received | ₹1.00 Cr | ₹0.56 Cr | ₹0.23 Cr | ₹0.37 Cr | ₹0.31 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | ₹0.08 Cr | ₹0.04 Cr | ₹1.23 Cr | ₹0.02 Cr |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | ₹0.38 Cr | ₹0.62 Cr | ₹0.02 Cr | ₹0.12 Cr | ₹0.58 Cr |
| Foreign Exchange Gains | ₹0.29 Cr | - | - | ₹0.69 Cr | - |
| Others | ₹0.53 Cr | ₹1.59 Cr | ₹0.65 Cr | ₹2.74 Cr | ₹0.22 Cr |
| Operating Profit | ₹32 Cr | ₹34 Cr | ₹26 Cr | ₹29 Cr | ₹26 Cr |
| Interest | ₹17 Cr | ₹15 Cr | ₹12 Cr | ₹11 Cr | ₹12 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹4.46 Cr | ₹3.12 Cr | ₹3.70 Cr | ₹2.77 Cr | ₹3.26 Cr |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹2.52 Cr | ₹1.76 Cr | ₹1.82 Cr | ₹2.03 Cr | ₹1.62 Cr |
| Other Interest | ₹10 Cr | ₹9.78 Cr | ₹6.80 Cr | ₹6.10 Cr | ₹7.28 Cr |
| PBDT | ₹15 Cr | ₹19 Cr | ₹14 Cr | ₹18 Cr | ₹14 Cr |
| Depreciation | ₹9.77 Cr | ₹10 Cr | ₹9.13 Cr | ₹9.04 Cr | ₹9.52 Cr |
| Profit Before Taxation & Exceptional Items | ₹5.14 Cr | ₹9.05 Cr | ₹4.75 Cr | ₹9.18 Cr | ₹4.10 Cr |
| Exceptional Income / Expenses | - | - | - | - | - |
| Profit Before Tax | ₹5.14 Cr | ₹9.05 Cr | ₹4.75 Cr | ₹9.18 Cr | ₹4.10 Cr |
| Provision for Tax | ₹-2.10 Cr | ₹1.60 Cr | ₹2.13 Cr | ₹3.48 Cr | ₹-0.61 Cr |
| Current Income Tax | - | ₹3.20 Cr | ₹2.59 Cr | ₹4.48 Cr | ₹0.38 Cr |
| Deferred Tax | ₹-1.96 Cr | ₹0.85 Cr | ₹0.10 Cr | ₹-1.94 Cr | ₹-0.99 Cr |
| Other taxes | ₹-0.14 Cr | ₹-2.45 Cr | ₹-0.55 Cr | ₹0.94 Cr | - |
| Profit After Tax | ₹7.24 Cr | ₹7.45 Cr | ₹2.62 Cr | ₹5.71 Cr | ₹4.71 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | ₹-0.02 Cr | ₹-0.05 Cr | ₹-0.05 Cr | ₹-0.09 Cr | ₹0.03 Cr |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹7.22 Cr | ₹7.39 Cr | ₹2.57 Cr | ₹5.61 Cr | ₹4.74 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹22 Cr | ₹15 Cr | ₹14 Cr | ₹9.45 Cr | ₹13 Cr |
| Appropriations | ₹29 Cr | ₹22 Cr | ₹16 Cr | ₹15 Cr | ₹17 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹1.96 Cr | ₹-0.07 Cr | ₹1.56 Cr | ₹1.48 Cr | ₹7.88 Cr |
| Equity Dividend % | ₹12.00 | ₹12.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Earnings Per Share | ₹4.53 | ₹4.68 | ₹1.64 | ₹3.79 | ₹3.20 |
| Adjusted EPS | ₹4.53 | ₹4.68 | ₹1.64 | ₹3.79 | ₹3.20 |
Compare Income Statement of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹120.1 Cr | -4.4% | -8.3% | -32.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -4.4% |
-8.3% |
-32.5% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses